Targeted Testing For Pancreatic Cancer: Avantect Vs. Multi-Cancer Tests 

The realm of cancer detection has seen notable advancements, with tests designed to detect a myriad of cancers and those precision-engineered for specific ones. A question then emerges: for a condition as critical as pancreatic cancer, should one lean towards a multi-cancer detection test like Grail’s Galleri or a targeted test like Avantect? Here’s why we advocate the latter. 

How is Pancreatic Cancer Diagnosed

In the ever-evolving landscape of medical diagnostics, the question is not just about “How do you test for pancreatic cancer?” but “What’s the most effective way to test for it?”  

The Underappreciated Link Between Pancreatic Cancer and Diabetes

Pancreatic cancer is a serious disease with more than 60,000 new cases each year in the U.S. and with expanded impact, that affects a substantial number of people. It’s the third leading cause of cancer-related deaths, and it’s predicted to become the second leading cause by 2030.